Summary:
- The article discusses a new approach to cancer treatment called "armed bystander molecules" that can enhance the immune system's ability to attack cancer cells.
- The approach involves engineering immune cells called CAR T cells to release signaling molecules that can activate other immune cells in the tumor microenvironment, leading to a more effective anti-cancer response.
- Preliminary studies in mice have shown promising results, with the armed bystander molecules improving the efficacy of CAR T cell therapy against solid tumors, and the researchers are now working to translate this approach to clinical trials.